Pharmafile Logo
Pharmafocus logo
Advanced Search

patient deaths

Showing 5 posts of 5 posts found.

acorda-therapeutics-inc-logo

Acorda scraps Parkinson’s drug after five trial deaths

November 20, 2017
Research and Development, Sales and Marketing Acorda therapeutics, Parkinson's, patient deaths, pharma

Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …

News
seattle_genetics

Four die in Seattle Genetics’ drug trial

January 3, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Seattle Genetics, patient deaths, trial hold

Seattle Genetics released that the FDA had placed a hold had been placed on clinical trials involving its experimental cancer …

News
chemo-web

Untested cancer drug suspected cause of three deaths at German alternative medicine centre

August 17, 2016
Research and Development 3-Bromopyruvate, Cancer, Germany, alternative medicine, patient deaths

The deaths of three patients at an alternative medicine clinic in Germany have prompted suspicion of a clinically untested cancer …

News

13 deaths in Aurinia’s lupus drug trial despite hitting Phase II target

August 16, 2016
Manufacturing and Production, Research and Development Aurinia, Phase II, biotech, patient deaths, voclosporin

Canadian biotech Aurinia Pharmaceuticals has announced the topline Phase IIb trial results of its lupus nephritis (LN) treatment voclosporin, which …

News
chemo-web

FDA suspends Juno Therapeutics cancer drug trial after patient deaths

July 8, 2016
Medical Communications, Research and Development FDA, juno therapeutics, patient deaths

Juno Therapeutics (NASDAQ: JUNO) has had its Phase II trial investigating JCAR015 in adult patients with relapsed or refractory B …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026